Every 8-K that Evolv Technologies Holdings, Inc. Warrant (EVLVW) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow EVLVW and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full EVLVW filings page.
Evolv Technologies Holdings, Inc. reported results of its annual stockholder meeting held on June 18, 2026. A total of 138,936,379 shares of Class A common stock were represented, equal to approximately 77.35% of shares outstanding as of the April 24, 2026 record date.
Stockholders elected Class II directors Neil Glat and Richard Shapiro to serve until the 2029 annual meeting. They also approved, on an advisory and non-binding basis, the compensation of the company’s named executive officers, and ratified the appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm for the year ending December 31, 2026.
Evolv Technologies Holdings is clarifying that some market data sites misreported its recent revenue figures and outlook. The company confirms Q1 2026 total revenue was $46.3 million, up from $32.0 million in Q1 2025, a 45% year-over-year increase.
Evolv also confirms it has raised its full-year 2026 total revenue guidance range to $175 million to $180 million. The update is meant to ensure investors are relying on the company’s own disclosures rather than incorrect third-party data.
Evolv Technologies Holdings reported strong first quarter 2026 results with revenue of $46.3 million, up 45% from $32.0 million a year earlier, driven by new customers and expanded deployments. Ending ARR reached $127.3 million, a 20% year-over-year increase, underscoring growth in recurring subscription-based business.
The company posted a net loss of $5.0 million, or $0.03 per share, compared with a $1.7 million loss, or $0.01 per share, in the prior-year quarter, but improved profitability on an adjusted basis. Adjusted EBITDA rose to $3.9 million from $2.1 million, delivering an 8.5% margin.
Management raised its 2026 total revenue outlook to a range of $175 million to $180 million, reflecting about 20% to 23% year-over-year growth, while reaffirming expectations for year-end ARR of $145 million to $150 million and positive full-year adjusted EBITDA with high single-digit margins.
Evolv Technologies Holdings, Inc. reported strong fourth quarter and full-year 2025 results and raised its outlook for 2026. Q4 2025 revenue reached $38.5 million, up 32% year over year, with ending ARR of $120.5 million, up 21%. The company generated Q4 net income of $10.9 million and Adjusted EBITDA of $1.8 million.
For 2025, revenue grew to $145.9 million, a 40% increase from 2024, while net loss narrowed to $33.1 million and Adjusted EBITDA improved to $11.1 million. Operating activities provided $18.7 million of cash, and cash, cash equivalents and marketable securities totaled $69.0 million at year-end.
For 2026, the company expects total revenue of $172–$178 million and ending ARR of $145–$150 million, with positive full-year Adjusted EBITDA and margins in the high single digits, driven by a higher mix of recurring subscription revenue.
Evolv Technologies Holdings, Inc. announced a Board change, with long-time director and early venture investor Bilal Zuberi resigning to pursue other endeavors, with no disagreements cited with leadership or the Board.
The company appointed Henrik Kühl, age 46, to its Board of Directors effective February 12, 2026, as a Class III director through the 2027 annual meeting. He will also serve on the Audit Committee. The Board determined that Kühl is independent under Nasdaq and SEC rules and qualifies as an “audit committee financial expert.”
Kühl brings more than 25 years of experience in corporate strategy and development, including his current role as Senior Vice President, Strategy & Corporate Development at Axon. He will receive compensation as a non-employee director under Evolv’s Director Compensation Policy.